全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

经方在高血压病治疗中的运用

Keywords: 高血压病,经方,中医药疗法

Full-Text   Cite this paper   Add to My Lib

Abstract:

经方在高血压病的治疗中前景广阔,具有缓解症状,改善体质以及血压难控因素等优势。该文系统回顾了经方在高血压前期、高血压病不同阶段、特殊类型高血压、继发性高血压以及血压难控因素中的运用。认为经方起效的前提在于对其客观指征的深刻把握,在于对该病现代病因病机及其演变规律的深刻认识。

References

[1]  Sliwa K, Stewart S, Gersh B J. Hypertension:a global perspective [J]. Circulation, 2011, 123:2892.
[2]  Schlaich M P,Sobotka P A,Krum H,et al.Renal sympathetic-nerve ablation for uncontrolled hypertension [J].N Engl J Med,2009,361 (9):932.
[3]  Keene L C, Davies P H. Drug-related erectile dysfunction [J]. Adverse Drug React Toxicol Rev, 1999, 18(1):5.
[4]  Xiong X J, Yang X C, Liu W, et al. Banxia baizhu tianma decoction for essential hypertension:a systematic review of randomized controlled trials [J]. Evid-Based Compl Alt Med, 2012, doi:10.1155/2012/271462.
[5]  Xiong X J, Yang X C, Feng B, et al. Zhen gan xi feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension:a systematic review of randomized controlled trials [J]. Evid-Based Compl Alt Med, 2013, doi:10.1155/2013/982380.
[6]  Wang J, Yang X C, Feng B, et al. Is Yangxue Qingnao granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension? [J]. Evid-Based Compl Alt Med, 2013, doi:10.1155/2013/540613.
[7]  Wang J, Xiong X J. Current situation and perspectives of clinical study in integrative medicine in China [J]. Evid-Based Compl Alt Med, 2012, doi:10.1155/2012/268542.
[8]  张京春,陈可冀.关于美国KNC-7高血压指南的评述[J].中国中西医结合杂志,2003,23(10):724.
[9]  Hajjar I, Kotchen T A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States (1988—2000) [J]. J Amer Med Assoc, 2003, 290:199.
[10]  Manios E, Tsivgoulis G, Koroboki E, et al. Impact of prehypertension on common carotid artery intima-media thickness and left ventricular mass [J]. Stroke, 2009, 40(4):1515.
[11]  Drukteinis J S, Roman M J, Fabsitz R R, et al. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults:the strong heart study [J]. Circulation, 2007, 115(2):221.
[12]  Toprak A, Wang H, Chen W, et al. Prehypertension and black-white contrasts in cardiovascular risk in young adults:Bogalusa heart study[J]. J Hypentens, 2009, 27(2):243.
[13]  Lloyd-Jones D M,Hong Y,Labarthe D,et al. Defining and setting national goals for cardiovascular health promotion and disease reduction:the American heart association\'s strategic impact goal through 2020 and beyond [J]. Circulation,2010,121:586.
[14]  Wang J, Xiong X J. Control strategy on hypertension in Chinese medicine [J]. Evid-Based Compl Alt Med, 2012, doi:10.1155/2012/284847.
[15]  Xiong X J, Yang X C, Liu Y M, et al. Chinese herbal formulas for treating hypertension in traditional Chinese medicine:perspective of modern science[J]. Hypertension Res, 2013, doi:10.1038/hr.2013.18.
[16]  熊兴江,王阶.基于药物客观指征的《方剂学》相关问题[J].中西医结合学报,2010,8(1):20.
[17]  熊兴江,王阶.基于方证对应理念的减少药物不良反应的思考[J].中国中药杂志,2010,35(4):536.
[18]  王阶,熊兴江.方证对应特征探讨[J].中医杂志,2010,51(3):200.
[19]  张京春,谢元华.陈可冀院士辨治冠心病医案的数据挖掘[J].世界中西医结合杂志,2008,3(1):4.
[20]  熊兴江,王阶.血脂异常辨治思路与方法[J].中国中药杂志,2010,35(10):1349.
[21]  唐补生,曹敏,李广浩,等.血压难控因素的中医辨识和治疗[J].辽宁中医杂志,2009,36(2):197.
[22]  Wang J, Xiong X J. Outcome measures of Chinese herbal medicine for hypertension:an overview of systematic reviews [J]. Evid-Based Compl Alt Med, 2012, doi:10.1155/2012/697237.
[23]  Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) [J]. J Hypertens, 2007, 25:1105.
[24]  Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management:a European society of hypertension task force document [J]. J Hypertens, 2009, 27:2121.
[25]  Feldman H A, Johannes C B, Derby C A, et al. Erectile dysfunction and coronary risk factors:prospective results from the Massachusetts male aging study [J]. Prev Med, 2000, 30(4):328.
[26]  Buranakitjaroen P, Phoojaroenchanachai M, Saravich S. Prevalence of erectile dysfunction among treated hypertensive males [J]. J Med Assoc Thai, 2006, 89(S5):S28.
[27]  Baumhakel M, Schlimmer N, Bohm M. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome [J]. Int J Impot Res, 2008, 20(5):493.
[28]  Wang J, Wang P Q, Xiong X J. Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine [J]. Int Med, 2012, doi:10.4172/2165-8048.1000113.
[29]  Chen K J, Hui K K, Lee M S, et al. The potential benefit of complementary/alternative medicine in cardiovascular diseases [J]. Evid-Based Compl Alt Med, 2012, doi:10.1155/2012/125029.
[30]  Xiong X J, Chu F Y, Li H X, et al. Clinical application of the TCM classic formulae for treating chronic bronchitis [J]. J Tradit Chin Med, 2011, 31 (1):69.
[31]  王阶.中医辨证治疗高血压病概述[J].中国临床医生,1999,27(12):17.
[32]  熊兴江,王阶.论高血压病的中医认识及经典名方防治策略[J].中医杂志,2011,52(23):1985.
[33]  刘巍,熊兴江,王阶.高血压病代谢紊乱及化浊平肝法的临床运用[J].中国中药杂志,2013,38(8):1251.
[34]  熊兴江,王阶.论半夏白术天麻汤在高血压病中的运用[J].中华中医药杂志,2012,27(11):2862.
[35]  Wang J, Yao K W, Yang X C, et al. Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension:a systematic review of randomized controlled trials [J]. Evid-Based Compl Alt Med, 2012, doi:10.1155/2012/714805.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133